0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Hepatology

Buy Now

AMPK-S6K1 Signaling Pathway as a Target for Treating Hepatic Insulin Resistance (Paperback, New) Loot Price: R1,285
Discovery Miles 12 850
AMPK-S6K1 Signaling Pathway as a Target for Treating Hepatic Insulin Resistance (Paperback, New): Sang Geon Kim, Je Cho, Hee...

AMPK-S6K1 Signaling Pathway as a Target for Treating Hepatic Insulin Resistance (Paperback, New)

Sang Geon Kim, Je Cho, Hee Yeon Kay

 (sign in to rate)
Loot Price R1,285 Discovery Miles 12 850 | Repayment Terms: R120 pm x 12*

Bookmark and Share

Expected to ship within 12 - 19 working days

Hepatic insulin resistance and altered insulin metabolism, as characterised by the desensitisation of hepatic parenchymal cells to insulin, play a role in the pathogenesis of liver disease, particularly resulting in steatosis and steatohepatitis. By the same token, type II diabetic patients are at higher risk for developing liver diseases, including steatosis, hepatitis, cirrhosis, and hepatocellular carcinoma. On the other hand, established liver disease from any cause leads to glucose intolerance and peripheral insulin resistance systemically. The link between insulin resistance and liver pathology reviewed in this book suggests that insulin resistance is closely related with a variety of liver diseases. Recent evidence indicates that the AMP activating protein kinase (AMPK) in conjunction with p70 ribosomal S6 kinase 1 (S6K1) serves as a key signalling pathway regulating insulin-dependent physiological functions; thus, this pathway serves as a target for the therapy of diseases associated with insulin resistance. In this chapter, the regulatory role of the AMPK-S6K1 pathway is discussed in terms of enhancing insulin receptor signalling with insulin receptor substrate-1/2 and phosphatidylinositol phosphate kinase activity, which may contribute to preventing and/or treating insulin resistance in the liver.

General

Imprint: nova science publishers
Country of origin: United States
Release date: 2010
First published: 2010
Authors: Sang Geon Kim • Je Cho • Hee Yeon Kay
Dimensions: 155 x 230 x 5mm (L x W x T)
Format: Paperback
Pages: 59
Edition: New
ISBN-13: 978-1-60876-693-2
Categories: Books > Medicine > Clinical & internal medicine > Hepatology
Promotions
LSN: 1-60876-693-4
Barcode: 9781608766932

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

You might also like..

Drug Hepatotoxicity, An Issue of Clinics…
Vinod Rustgi Hardcover R2,264 Discovery Miles 22 640
Advances in Cholestatic Liver Diseases…
Cynthia Levy Hardcover R1,795 Discovery Miles 17 950
Drug-Induced Liver Injury, Volume 85
Anup Ramachandran, Hartmut Jaeschke Hardcover R6,960 R5,822 Discovery Miles 58 220
Liver Cirrhosis - Debates and Current…
Georgios Tsoulfas Hardcover R3,334 Discovery Miles 33 340
Hepatitis A and Other Associated…
Costin Teodor Streba, Cristin Constantin Vere, … Hardcover R3,323 Discovery Miles 33 230
Liver Research and Clinical Management
Luis Rodrigo Hardcover R3,360 Discovery Miles 33 600
Primary Biliary Cholangitis , An Issue…
Binu V John Hardcover R2,156 Discovery Miles 21 560
Hepatobiliary Imaging, An Issue of…
Benjamin M. Yeh, Frank H. Miller Hardcover R2,770 Discovery Miles 27 700
Liver Pathophysiology - Therapies and…
Pablo Muriel Hardcover R3,934 Discovery Miles 39 340
Nonalcoholic Fatty Liver Disease - An…
Emad Hamdy Gad Hardcover R3,321 Discovery Miles 33 210
Complexities in Liver Transplantation
Dylan Long Hardcover R2,595 R2,363 Discovery Miles 23 630
Portal Hypertension - Recent Advances
Xingshun Qi Hardcover R3,311 Discovery Miles 33 110

See more

Partners